• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Rating of "Buy" from Brokerages

    Source: Buzz FX / 09 Oct 2024 03:01:11   America/New_York


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Average Rating of "Buy" from Brokerages Written by MarketBeat October 9, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) has been assigned an
    Read more...
Share on,